VanB-Type Enterococcus faecium Clinical Isolate Successively Inducibly Resistant to, Dependent on, and Constitutively Resistant to Vancomycin

Antimicrobial Agents and Chemotherapy
2009.0

Abstract

Three Enterococcus faecium strains isolated successively from the same patient, vancomycin-resistant strain BM4659, vancomycin-dependent strain BM4660, and vancomycin-revertant strain BM4661, were indistinguishable by pulsed-field gel electrophoresis and harbored plasmid pIP846, which confers VanB-type resistance. The vancomycin dependence of strain BM4660 was due to mutation P(175)L, which suppressed the activity of the host Ddl D-Ala:D-Ala ligase. Reversion to resistance in strain BM4661 was due to a G-to-C transversion in the transcription terminator of the vanRS(B) operon that lowered the free energy of pairing from -13.08 to -6.65 kcal/mol, leading to low-level constitutive expression of the resistance genes from the P(RB) promoter, as indicated by analysis of peptidoglycan precursors and of VanX(B) D,D-dipeptidase activity. Transcription of the resistance genes, studied by Northern hybridization and reverse transcription, initiated from the P(YB) resistance promoter, was inducible in strains BM4659 and BM4660, whereas it started from the P(RB) regulatory promoter in strain BM4661, where it was superinducible. Strain BM4661 provides the first example of reversion to vancomycin resistance of a VanB-type dependent strain not due to a compensatory mutation in the ddl or vanS(B) gene. Instead, a mutation in the transcription terminator of the regulatory genes resulted in transcriptional readthrough of the resistance genes from the P(RB) promoter in the absence of vancomycin.

Knowledge Graph

Similar Paper

VanB-Type Enterococcus faecium Clinical Isolate Successively Inducibly Resistant to, Dependent on, and Constitutively Resistant to Vancomycin
Antimicrobial Agents and Chemotherapy 2009.0
New Combinations of Mutations in VanD-Type Vancomycin-Resistant Enterococcus faecium , Enterococcus faecalis , and Enterococcus avium Strains
Antimicrobial Agents and Chemotherapy 2009.0
vanM , a New Glycopeptide Resistance Gene Cluster Found in Enterococcus faecium
Antimicrobial Agents and Chemotherapy 2010.0
Isolation of VanB-Type Enterococcus faecalis Strains from Nosocomial Infections: First Report of the Isolation and Identification of the Pheromone-Responsive Plasmids pMG2200, Encoding VanB-Type Vancomycin Resistance and a Bac41-Type Bacteriocin, and pMG2201, Encoding Erythromycin Resistance and Cytolysin (Hly/Bac)
Antimicrobial Agents and Chemotherapy 2009.0
VanA-Type Vancomycin-ResistantStaphylococcus aureus
Antimicrobial Agents and Chemotherapy 2009.0
vanD and vanG -Like Gene Clusters in a Ruminococcus Species Isolated from Human Bowel Flora
Antimicrobial Agents and Chemotherapy 2007.0
Mutated Response Regulator graR Is Responsible for Phenotypic Conversion of Staphylococcus aureus from Heterogeneous Vancomycin-Intermediate Resistance to Vancomycin-Intermediate Resistance
Antimicrobial Agents and Chemotherapy 2008.0
Specificity of Induction of the vanA and vanB Operons in Vancomycin-Resistant Enterococci by Telavancin
Antimicrobial Agents and Chemotherapy 2010.0
Fitness Cost of VanA-Type Vancomycin Resistance in Methicillin-Resistant Staphylococcus aureus
Antimicrobial Agents and Chemotherapy 2009.0
Genomic Analysis Reveals a Point Mutation in the Two-Component Sensor Gene graS That Leads to Intermediate Vancomycin Resistance in Clinical Staphylococcus aureus
Antimicrobial Agents and Chemotherapy 2008.0